Alembic Pharma gets USFDA approval for Glycopyrrolate Injection USP
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
The symposium was organized to provide an opportunity to highlight the advances of aortic surgery and to discuss the future of aortic aneurysm management.
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
To set up 50 lifestyle modification centres across the UAE in the next 24 months
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Philips AI-powered interventional and diagnostic smart systems enhances diagnostic confidence, drive greater efficiency, and improve patient outcomes
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
The Sri Sathya Sai Sanjeevani Super Speciality Hospital in Batticaloa will begin its operations by conducting free paediatric cardiac care surgeries and interventions in the next few days
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Dr Sai Satish, Sr. Consultant Interventional Cardiologist performs India’s first 3 successful G4-Transcatheter Edge to Edge (G4–TEER) mitral valve repairs
Subscribe To Our Newsletter & Stay Updated